KEEL
Price
$2.23
Change
-$0.17 (-7.08%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.48B
21 days until earnings call
Intraday BUY SELL Signals
STEX
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
43M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KEEL vs STEX

KEEL vs STEX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
KEEL vs. STEX commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KEEL is a Hold and STEX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KEEL with price predictions
Oct 21, 2026

KEEL sees MACD Histogram just turned negative

KEEL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 30, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 41 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KEEL as a result. In 81 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

KEEL moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KEEL crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

The 50-day moving average for KEEL moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KEEL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for KEEL entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +3.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where KEEL advanced for three days, in 216 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

KEEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.509) is normal, around the industry mean (2.639). P/E Ratio (-3.200) is within average values for comparable stocks, (16.561). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.109) among similar stocks. P/S Ratio (10.684) is also within normal values, averaging (141.758).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. KEEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KEEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for STEX with price predictions
Oct 21, 2026

Momentum Indicator for STEX turns negative, indicating new downward trend

STEX saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In 76 of the 79 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for STEX turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 46 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

STEX moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

STEX broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for STEX entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +15.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in 220 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.295) is normal, around the industry mean (3.638). P/E Ratio (-0.041) is within average values for comparable stocks, (8.944). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.191) among similar stocks. STEX's P/S Ratio (526.316) is very high in comparison to the industry average of (16.763).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

FUNDAMENTALS RATINGS
KEEL vs STEX: Fundamental Ratings
KEEL
STEX
OUTLOOK RATING
1..100
5462
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9093
P/E GROWTH RATING
1..100
109
SEASONALITY SCORE
1..100
3950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KEEL's Valuation (48) in the null industry is somewhat better than the same rating for STEX (99) in the Medical Specialties industry. This means that KEEL’s stock grew somewhat faster than STEX’s over the last 12 months.

KEEL's Profit vs Risk Rating (100) in the null industry is in the same range as STEX (100) in the Medical Specialties industry. This means that KEEL’s stock grew similarly to STEX’s over the last 12 months.

KEEL's SMR Rating (98) in the null industry is in the same range as STEX (100) in the Medical Specialties industry. This means that KEEL’s stock grew similarly to STEX’s over the last 12 months.

KEEL's Price Growth Rating (90) in the null industry is in the same range as STEX (93) in the Medical Specialties industry. This means that KEEL’s stock grew similarly to STEX’s over the last 12 months.

STEX's P/E Growth Rating (9) in the Medical Specialties industry is in the same range as KEEL (10) in the null industry. This means that STEX’s stock grew similarly to KEEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KEELSTEX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend about 1 month ago
86%
Bullish Trend about 1 month ago
86%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (KEEL: $2.40 vs. STEX: $0.37)
Brand notoriety: KEEL and STEX are both not notable
KEEL represents the Information Technology Services, while STEX is part of the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: KEEL: 71% vs. STEX: 68%
Market capitalization -- KEEL: $1.48B vs. STEX: $43M
KEEL [@Information Technology Services] is valued at $1.48B. STEX’s [@Investment Banks/Brokers] market capitalization is $43M. The market cap for tickers in the [@Information Technology Services] industry ranges from $100 to $236.91B. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $293.71B. The average market capitalization across the [@Information Technology Services] industry is $10.28B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KEEL’s FA Score shows that 1 FA rating(s) are green while STEX’s FA Score has 1 green FA rating(s).

  • KEEL’s FA Score: 1 green, 4 red.
  • STEX’s FA Score: 1 green, 4 red.
According to our system of comparison, KEEL is a better buy in the long-term than STEX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KEEL’s TA Score shows that 4 TA indicator(s) are bullish while STEX’s TA Score has 3 bullish TA indicator(s).

  • KEEL’s TA Score: 4 bullish, 7 bearish.
  • STEX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both KEEL and STEX are a bad buy in the short-term.

Price Growth

KEEL (@Information Technology Services) experienced а -5.88% price change this week, while STEX (@Investment Banks/Brokers) price change was -14.16% for the same time period.

The average weekly price growth across all stocks in the @Information Technology Services industry was -2.60%. For the same industry, the average monthly price growth was -6.41%, and the average quarterly price growth was -8.30%.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -5.17%. For the same industry, the average monthly price growth was -16.77%, and the average quarterly price growth was -12.77%.

Reported Earning Dates

KEEL is expected to report earnings on Nov 12, 2026.

STEX is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Information Technology Services (-2.60% weekly)

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

@Investment Banks/Brokers (-5.17% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
KEEL
Daily Signal:
Gain/Loss:
STEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

KEEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, KEEL has been closely correlated with CLSK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if KEEL jumps, then CLSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KEEL
1D Price
Change %
KEEL100%
+2.56%
CLSK - KEEL
76%
Closely correlated
+3.80%
HIVE - KEEL
76%
Closely correlated
+2.78%
APLD - KEEL
74%
Closely correlated
+8.54%
HUT - KEEL
72%
Closely correlated
+3.68%
RIOT - KEEL
72%
Closely correlated
+1.82%
More

STEX and

Correlation & Price change

A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEX
1D Price
Change %
STEX100%
-1.60%
KEEL - STEX
35%
Loosely correlated
+2.56%
BTBT - STEX
34%
Loosely correlated
+4.67%
BMNR - STEX
33%
Loosely correlated
+5.00%
PWCM - STEX
32%
Poorly correlated
+3.81%
CLSK - STEX
32%
Poorly correlated
+3.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMAT408.943.96
+0.98%
Applied Materials
DTSQ11.550.10
+0.87%
DT Cloud Star Acquisition Corporation
KEX137.241.03
+0.76%
Kirby Corp
TJGC31.89N/A
N/A
TJGC Group Limited
BFC142.04-6.30
-4.25%
Bank First Corp